Correction: LDB2 is a novel diagnostic and prognostic biomarker and inhibits bladder cancer metastasis by activating p38 MAPK/ERK1/2/JNK signaling pathway

Clinical and Experimental Medicine 2026 Open access

Read full text

Authors: Yue Li, Bin Zhao, Wenzhi Gao, Yucai Wu, Tai Tian, Shimeng Zhao, Jilong Zhang, Ran Li, Shiming He, Yanqing Gong, Jianguo Ma, Xuesong Li

DOI: 10.1007/s10238-025-02009-y

Cited by: 0

Fields of Study & Subjects

Melanoma and MAPK Pathways Bladder and Urothelial Cancer Treatments NF-κB Signaling Pathways